TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

INFUVITE ADULT

ALPHA-TOCOPHEROL ACETATE
Approved 2000-05-18
1
Indication
--
Phase 3 Trials
25
Years on Market

Details

Status
Prescription
First Approved
2000-05-18
Routes
INTRAVENOUS
Dosage Forms
SOLUTION

INFUVITE ADULT Approval History

Loading approval history...

What INFUVITE ADULT Treats

1 FDA approvals

Originally approved for its first indication in 2000 .

  • Other (1)
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

INFUVITE ADULT FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

INFUVITE ADULT is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition. The physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. INFUVITE ADULT is a combination of vitamins indicated for prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.